Citadel Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-29,511
| Closed | -$330K | – | 7064 |
|
|
2022
Q4 | $330K | Sell |
29,511
-266,547
| -90% | -$2.98M | ﹤0.01% | 4245 |
|
|
2022
Q3 | $1.66M | Buy |
296,058
+72,593
| +32% | +$408K | ﹤0.01% | 2922 |
|
|
2022
Q2 | $968K | Buy |
223,465
+117,584
| +111% | +$509K | ﹤0.01% | 3442 |
|
|
2022
Q1 | $1.23M | Sell |
105,881
-24,805
| -19% | -$289K | ﹤0.01% | 3545 |
|
|
2021
Q4 | $2.39M | Sell |
130,686
-1,813
| -1% | -$33.1K | ﹤0.01% | 2856 |
|
|
2021
Q3 | $1.57M | Buy |
132,499
+29,396
| +29% | +$348K | ﹤0.01% | 3278 |
|
|
2021
Q2 | $1.77M | Sell |
103,103
-129,103
| -56% | -$2.22M | ﹤0.01% | 3336 |
|
|
2021
Q1 | $4.25M | Sell |
232,206
-50,000
| -18% | -$914K | ﹤0.01% | 2297 |
|
|
2020
Q4 | $5.31M | Buy |
282,206
+5,000
| +2% | +$94.1K | ﹤0.01% | 1716 |
|
|
2020
Q3 | $5.85M | Sell |
277,206
-4,336
| -2% | -$91.5K | ﹤0.01% | 1406 |
|
|
2020
Q2 | $8.13M | Buy |
281,542
+261,668
| +1,317% | +$7.56M | ﹤0.01% | 1215 |
|
|
2020
Q1 | $696K | Buy |
+19,874
| New | +$696K | ﹤0.01% | 3150 |
|